ARCHIVES

NCAB May Determine Fate Of NCOG, Possibly Other Regional Groups; Simone Denies CCIRC Prejudice

This article is from The Cancer Letter archive.

Vol. 07 No. 19 | May 8, 1981

Download PDF Visit The Full Archive

Related Articles

NIH Director Varmus Names President of Sloan-Kettering, Succeeding Mark

October 15, 1999

DSMB Recommends Discontinuing Phase III Perifosine Combination Trial

March 29, 2013

Clinical Oncology Study Section In Draft; ET2 May Be Eliminated, NIH Official Says

February 13, 1998

Natcher Subcommittee Kills Recision, Save NCI $17 Million

May 2, 1980

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

Cancer Program Should Get $2 Billion A Year, Amos Says; “Feds Short On Money, Long of Regs”: Yarbro

March 25, 1983